'If it almost kills you that means it's working!' Cultural models of chemotherapy expressed in a cancer support group

Social Science and Medicine

Volumn 68, Issue 1, 2009, Pages 169-176

  Bell, Kirsten ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Canada; Cancer; Chemotherapy; Cultural models; Lay understandings; Suffering; Support groups

Indexed keywords

CAPECITABINE; FLUOROURACIL;

CANCER; CHEMOTHERAPY; DISEASE TREATMENT; MODELING;

ADJUVANT CHEMOTHERAPY; ANXIETY; ARTICLE; BIOMEDICINE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RESEARCH; CANCER SURVIVOR; CANCER THERAPY; COLORECTAL CANCER; CULTURAL FACTOR; ETHNOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PROSTATE CANCER; RISK ASSESSMENT; SUPPORT GROUP;

ANTHROPOLOGY, CULTURAL; ANTINEOPLASTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CANADA; CANCER CARE FACILITIES; COLORECTAL NEOPLASMS; CULTURE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MODELS, PSYCHOLOGICAL; PAIN; QUALITATIVE RESEARCH; SELF-HELP GROUPS; SOCIOLOGY, MEDICAL; TREATMENT OUTCOME;

CANADA; NORTH AMERICA;

EID: 57649096278     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2008.10.023     Document Type: Article

References (58)

1. Abel G.A., and Glinert L.H. Chemotherapy as language: sound symbolism in cancer medication names. Social Science & Medicine 66 (2008) 1863-1869
2. Balshem M. Cancer, control, and causality: talking about cancer in a working-class community. American Ethnologist 18 1 (1991) 152-172
3. Beisecker A.E., Cook M.R., Ashworth J., Hayes J., Brecheisen M., Helmig L., et al. Side effects of adjuvant chemotherapy: perceptions of node-negative breast cancer patients. Psycho-Oncology 6 (1997) 85-93
4. Borner M.M., Schoffski P., de Wit R., Caponigro F., Comella G., Sulkes A., et al. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. European Journal of Cancer 38 (2002) 349-358
5. Breastcancer.org. Myths about chemotherapy (2008). http://www.breastcancer.org/treatment/chemotherapy/chemo.jsp Accessed 20.08.08
6. Browall M., Gaston-Johansson F., and Danileson E. Postmenopausal women with breast cancer. Cancer Nursing 29 1 (2006) 34-42
7. Canadian Cancer Society. Chemotherapy: A guide for people with cancer (2004), Canadian Cancer Society, Toronto
8. Catania C., Didier F., Leon M.E., Sbanooto A., Mariani L., Nole F., et al. Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer. Breast Cancer Research & Treatment 92 (2005) 265-272
9. Charles C., Redko C., Whelan T., Gafni A., and Reyno L. Doing nothing is no choice: lay constructions of treatment decision-making among women with early-stage breast cancer. Sociology of Health & Illness 20 1 (1998) 71-95
10. Clark R.A. Reel oncology: how Hollywood films portray cancer. Cancer Control Journal 6 5 (1999)
11. Cold Spring Harbour Laboratory. Inside cancer (2006). http://www.insidecancer.org/ Accessed 29.04.08
12. Coreil J., Wilke J., and Pintado I. Cultural models of illness and recovery in breast cancer support groups. Qualitative Health Research 14 7 (2004) 905-923
13. Cowley L., Heyman B., Stanton M., and Milner S.J. How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective. Journal of Advanced Nursing 31 2 (2000) 314-321
14. DiGiacomo S. Biomedicine as a cultural system: An anthropologist in the Kingdom of the sick. In: Baer H. (Ed). Encounters with biomedicine: Case studies in medical anthropology (1987), Gordon & Breach, New York 315-346
15. Duric V.M., Butow P.N., Sharpe L., Boyle F., Beith B., Wilcken N.R.C., et al. Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psycho-Oncology 16 (2007) 48-59
16. Etkin N.L., and Tan M.L. Medicines: Meanings and contexts (1994), University of Amsterdam Press, Amsterdam
17. Etkin N.L., Ross P.J., and Muazzamu I. The rational basis of 'irrational' drug use: Pharmaceuticals in the context of development. In: Hahn R.A. (Ed). Anthropology in public health: Bridging differences in culture and society (1999), Oxford University Press, New York 165-181
18. Fallowfield L., Atkins L., Catt S., Cox A., Coxon C., Langridge C., et al. Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Annals of Oncology 17 (2006) 205-210
19. Frith H., and Harcourt D. Using photographs to capture women's experiences of chemotherapy: reflecting on the method. Qualitative Health Research 17 (2007) 1340-1350
20. Frith H., Harcourt D., and Fussell A. Anticipating an altered appearance: women undergoing chemotherapy treatment for breast cancer. European Journal of Oncology Nursing 11 (2007) 385-391
21. Gibbs Jr. R.W., and Frank H. Embodied metaphor in women's narratives about their experiences with cancer. Health Communication 14 2 (2002) 139-165
22. Good M.-J.V., Good B.J., Schaffer C., and Lind S.E. American oncology and the discourse on hope. Culture, Medicine & Psychiatry 14 (1990) 59-79
23. Greer S. The psychological dimension in cancer treatment. Social Science & Medicine 18 4 (1984) 345-349
24. Gurney H. How to calculate the dose of chemotherapy. British Journal of Cancer 86 (2002) 1297-1302
25. Haydon A. Adjuvant chemotherapy in colon cancer: what is the evidence?. Internal Medicine Journal 33 (2003) 119-124
26. Herron L.-M. Building effective cancer support groups: Report to the Department of Health and Ageing (2005), Cancer Council Australia, Sydney
27. Jansen S.J.T., Kievit J., Nooij M.A., de Haes J.C.J.M., Overpelt I.M.E., van Slooten H., et al. Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?. British Journal of Cancer 84 12 (2001) 1577-1585
28. Jansen S.J.T., Otten W., Baas-Thijssen M.C.M., van de Velde C.J.H., Nortier J.W.R., and Stiggelbout A.M. Explaining differences in attitude toward adjuvant chemotherapy between experienced and inexperienced breast cancer patients. Journal of Clinical Oncology 23 27 (2005) 6623-6630
29. Kleinman A.M. The illness narratives: Suffering, healing and the human condition (1988), Basic Books, New York
30. Labianca R., Milesi L., Mosconi S., Pessi M.A., Beretta G.D., and Quadri A. The role of adjuvant chemotherapy in colon cancer. Surgical Oncology 16 Suppl. 1 (2007) S93-S96
31. Lemare F., Mateus C., Camps S., Montheil V., Henguelle E., Cacheux W., et al. Chemotherapy in non-selected elderly patients: factors influencing dose-intensity and toxicity. Journal of Clinical Oncology 25 18S (2007)
32. Lindley C., McCune J.S., Thomason T.E., Lauder D., Sauls A., Adkins S., et al. Perception of chemotherapy side effects: cancer versus noncancer patients. Cancer Practice 7 2 (1999) 59-65
33. Liu G., Franssen E., Fitch M.I., and Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. Journal of Clinical Oncology 15 1 (1997) 110-115
34. Magee S., and Scalzo K. Picking up the pieces: Moving forward after surviving cancer (2006), Raincoast Books, Vancouver, Canada
35. Martin E. Flexible bodies: Tracking immunity in American culture from the days of polio to the age of AIDS (1994), Beacon Press, Boston
36. Mathews H.F. Negotiating cultural consensus in a breast cancer self-help group. Medical Anthropology Quarterly 14 3 (2000) 394-413
37. Maughan T.S. Adjuvant chemotherapy for colorectal cancer. British Journal of Cancer 85 10 (2001) 1422-1424
38. Moerman D. Meaning, medicine and the 'placebo effect' (2002), Cambridge University Press, Cambridge
39. Moore R. African American women and breast cancer. Cancer Nursing 24 1 (2001) 35-43
40. Mullan F. Seasons of survival: reflections of a physician with cancer. New England Journal of Medicine 313 (1985) 270-273
41. Nerenz D.R., Leventhal H., and Love R.R. Emotional distress during chemotherapy. Cancer 50 (1982) 1020-1027
42. Neugut A.I., Matasar M., Wang X., McBride R., Jacobson J.S., Tsai W.-Y., et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. Journal of Clinical Oncology 24 15 (2006) 2368-2375
43. Nichter M., and Nichter M. Anthropology and international health: Asian case studies (1996), Routledge, England
44. O'Connell M.J., Mailliard J.A., Kahn M.J., Macdonald J.S., Haller D.G., Mayer R.J., et al. Controlled trial of fluorouracil and lose-dose leucovorin given for 6 months as post-operative adjuvant therapy for colon cancer. Journal of Clinical Oncology 15 1 (1997) 246-250
45. Penson P.T., Schapira L., Daniels K.J., Chabner B.A., and Lynch Jr. T.J. Cancer as metaphor. The Oncologist 9 (2004) 708-716
46. Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. Journal of Supportive Oncology 1 4 Suppl. 2 (2003) 18-24
47. Richer M.-C., and Ezer H. Living in it, living with it, and moving on: dimensions of meaning during chemotherapy. Oncology Nursing Forum 29 1 (2002) 113-119
48. Rieff D. Swimming in a sea of death: A son's memoir (2008), Simon & Schuster, New York
49. Rosman S. Cancer and stigma: experience of patients with chemotherapy-induced alopecia. Patient Education & Counseling 52 (2004) 333-339
50. Saillant F. Discourse, knowledge and experience of cancer: a life story. Culture, Medicine & Psychiatry 14 (1990) 81-104
51. Sanjek R. Keeping ethnography alive in an urbanizing world. Human Organization 59 3 (2000) 280-288
52. Sinding C., and Gray R. Active aging-spunky survivorship? Discourses and experiences of the years beyond breast cancer. Journal of Aging Studies 19 (2005) 147-161
53. Skott C. Expressive metaphors in cancer narratives. Cancer Nursing 25 3 (2002) 230-235
54. Sontag S. Illness as metaphor and AIDS and its metaphors (1977/1990), Picador, New York
55. Stiggelbout A.M., and de Haes J.C.J.M. Patient preference for cancer therapy: An overview of measurement approaches. Journal of Clinical Oncology 19 1 (2001) 220-230
56. Sun W., and Haller D.G. Adjuvant therapy of colon cancer. Seminars in Oncology 32 1 (2005) 95-102
57. Twelves C., Gollins S., Grieve R., and Samuel L. A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer. Annals of Oncology 17 (2006) 329-345
58. University of Wisconsin Health. Health information: be wise about antibiotics (2008). http://www.uwhealth.org/servlet/Satellite%3Fcid=1113313581133&pagename=B_EXTRANET_HEALTH_INFORMATION%2FFlexMember%2FShow_Public_HFFY&c=FlexGroup Accessed 17.04.08